Harry Klinefelter
Harry Klinefelter was an American endocrinologist best known for his identification and description of Klinefelter syndrome, a genetic condition affecting males.
Early Life and Education[edit | edit source]
Harry Klinefelter was born on March 20, 1912, in Baltimore, Maryland. He attended Johns Hopkins University, where he earned his medical degree in 1937. During his time at Johns Hopkins, Klinefelter developed an interest in endocrinology, the branch of medicine that deals with the endocrine system, its diseases, and its specific secretions known as hormones.
Career[edit | edit source]
After completing his medical degree, Klinefelter joined the Massachusetts General Hospital in Boston, Massachusetts, where he worked under the mentorship of Dr. Fuller Albright, a pioneer in the field of endocrinology. It was during his tenure at Massachusetts General Hospital that Klinefelter made his most significant contribution to medical science.
Klinefelter Syndrome[edit | edit source]
In 1942, Klinefelter, along with Dr. Albright and Dr. E. C. Reifenstein, published a paper describing a group of nine men who exhibited a set of symptoms including small testes, enlarged breasts, and sparse facial and body hair. This condition was later named Klinefelter syndrome in his honor. Klinefelter syndrome is a genetic disorder caused by the presence of an extra X chromosome in males (47,XXY instead of the typical 46,XY).
Later Life and Legacy[edit | edit source]
Klinefelter continued his work in endocrinology and made several other contributions to the field. He held various academic and clinical positions throughout his career, including a faculty position at Harvard Medical School. Klinefelter passed away on February 20, 1990, but his legacy lives on through the continued study and treatment of Klinefelter syndrome.
See Also[edit | edit source]
- Endocrinology
- Genetic disorders
- Massachusetts General Hospital
- Johns Hopkins University
- Harvard Medical School
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD